Institution
Yonsei University
Education•Seoul, South Korea•
About: Yonsei University is a education organization based out in Seoul, South Korea. It is known for research contribution in the topics: Population & Cancer. The organization has 50162 authors who have published 106172 publications receiving 2279044 citations. The organization is also known as: Yonsei.
Topics: Population, Cancer, Medicine, Thin film, Breast cancer
Papers published on a yearly basis
Papers
More filters
••
University of Utah1, University of Yamanashi2, Tokyo Institute of Technology3, Hanyang University4, Tokyo University of Science5, Kindai University6, Yonsei University7, Osaka City University8, University of Tokyo9, Kanagawa University10, Saitama University11, Rutgers University12, Tokyo City University13, Waseda University14, Chiba University15, Ewha Womans University16, Kyoto University17, Kōchi University18, Ritsumeikan University19, Université libre de Bruxelles20, Chungnam National University21, Hiroshima City University22, National Institute of Radiological Sciences23, Ehime University24
TL;DR: The Telescope Array experiment is supported by the Japan Society for the Promotion of Science through Grants-in-Aids for Scientific Research on Specially Promoted Research (21000002) "Extreme Phenomena in the Universe Explored by Highest Energy Cosmic Rays" and for scientific research (S) (19104006), and the Inter-University Research Program of the Institute for Cosmic Ray Research.
Abstract: The Telescope Array experiment is supported by the Japan Society for the Promotion of Science through Grants-in-Aids for Scientific Research on Specially Promoted Research (21000002) "Extreme Phenomena in the Universe Explored by Highest Energy Cosmic Rays" and for Scientific Research (S) (19104006), and the Inter-University Research Program of the Institute for Cosmic Ray Research; by the U.S. National Science Foundation awards PHY-0307098, PHY-0601915, PHY-0703893, PHY-0758342, and PHY-0848320 (Utah), and PHY-0649681 (Rutgers); by the National Research Foundation of Korea (2006-0050031, 2007-0056005, 2007-0093860, 2010-0011378, 2010-0028071, R32-10130, 2011-0002617); by the Russian Academy of Sciences, RFBR grants 10-02-01406a and 11-02-01528a (INR), IISN project No. 4.4509.10 and Belgian Science Policy under IUAP VI/11 (ULB). The foundations of Dr. Ezekiel R. and Edna Wattis Dumke, Willard L. Eccles and the George S. and Dolores Dore Eccles all helped with generous donations. The State of Utah supported the project through its Economic Development Board, and the University of Utah through the Office of the Vice President for Research. The experimental site became available through the cooperation of the Utah School and Institutional Trust Lands Administration (SITLA), U. S. Bureau of Land Management, and the U. S. Air Force. We also thank the people and the officials of Millard County, Utah for their steadfast and warm support. We gratefully acknowledge the contributions from the technical staffs of our home institutions. An allocation of computer time from the Center for High Performance Computing at the University of Utah is gratefully acknowledged.
272 citations
••
TL;DR: It is reported that Mtb Eis plays essential roles in modulating macrophage autophagy, inflammatory responses, and cell death via a reactive oxygen species (ROS)-dependent pathway and suppresses host innate immune defenses by modulating autophagic activation and cytokine production.
Abstract: The “enhanced intracellular survival” (eis) gene of Mycobacterium tuberculosis (Mtb) is involved in the intracellular survival of M. smegmatis. However, its exact effects on host cell function remain elusive. We herein report that Mtb Eis plays essential roles in modulating macrophage autophagy, inflammatory responses, and cell death via a reactive oxygen species (ROS)-dependent pathway. Macrophages infected with an Mtb eis-deletion mutant H37Rv (Mtb-Δeis) displayed markedly increased accumulation of massive autophagic vacuoles and formation of autophagosomes in vitro and in vivo. Infection of macrophages with Mtb-Δeis increased the production of tumor necrosis factor-α and interleukin-6 over the levels produced by infection with wild-type or complemented strains. Elevated ROS generation in macrophages infected with Mtb-Δeis (for which NADPH oxidase and mitochondria were largely responsible) rendered the cells highly sensitive to autophagy activation and cytokine production. Despite considerable activation of autophagy and proinflammatory responses, macrophages infected with Mtb-Δeis underwent caspase-independent cell death. This cell death was significantly inhibited by blockade of autophagy and c-Jun N-terminal kinase-ROS signaling, suggesting that excessive autophagy and oxidative stress are detrimental to cell survival. Finally, artificial over-expression of Eis or pretreatment with recombinant Eis abrogated production of both ROS and proinflammatory cytokines, which depends on the N-acetyltransferase domain of the Eis protein. Collectively, these data indicate that Mtb Eis suppresses host innate immune defenses by modulating autophagy, inflammation, and cell death in a redox-dependent manner.
272 citations
••
TL;DR: Asymptomatic patients may be contagious and thus a potential source of transmission of COVID-19, and more than half of the patients without any symptoms present with CT abnormalities.
272 citations
••
Tom Baker Cancer Centre1, Harvard University2, University of Ulsan3, Cleveland Clinic4, Princess Margaret Cancer Centre5, University of Toronto6, Stanford University7, City of Hope National Medical Center8, Japanese Foundation for Cancer Research9, University of British Columbia10, Aarhus University Hospital11, Queen Elizabeth II Health Sciences Centre12, Huntsman Cancer Institute13, Wayne State University14, Yonsei University15, University of Calgary16
TL;DR: The IMDC prognostic model in the second-line targeted therapy setting has an improved prognostic performance and is applicable to a more contemporary patient cohort than that of the three-factor MSKCC model.
Abstract: Summary Background Previous prognostic models for second-line systemic therapy in patients with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We sought to validate the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model in patients with metastatic renal cell carcinoma receiving next-line targeted therapy after progression on first-line targeted therapy. Methods In this population-based study, we analysed patients who received second-line targeted therapy for metastatic renal cell carcinoma at 19 centres in Canada, USA, Greece, Japan, Singapore, South Korea, and Denmark. The primary endpoint was overall survival since the initiation of second-line therapy. We compared the prognostic performance of the IMDC model with the three-factor MSKCC model used for previously treated patients for overall survival since the start of second-line targeted therapy. Findings Between Jan 1, 2005, and Nov 30, 2012, we included 1021 patients treated with second-line targeted therapy. Median overall survival since the start of second-line targeted therapy was 12·5 months (95% CI 11·3–14·3). Five of six predefined factors in the IMDC model (anaemia, thrombocytosis, neutrophilia, Karnofsky performance status [KPS] Interpretation The IMDC prognostic model can be applied to patients previously treated with targeted therapy, in addition to previously validated populations in first-line targeted therapy. The IMDC prognostic model in the second-line targeted therapy setting has an improved prognostic performance and is applicable to a more contemporary patient cohort than that of the three-factor MSKCC model. Funding DF/HCC Kidney Cancer SPORE P50 CA101942-01, Kidney Cancer Research Network of Canada, Canadian Institute for Health Research, Trust Family, Loker Pinard, Michael Brigham, and Gerald DeWulf.
271 citations
••
11 Jul 2013
TL;DR: In this paper, the ALICE detector was used to measure the long-range correlations between trigger particles and various species of charged associated particles (unidentified particles, pions, kaons, protons and antiprotons).
Abstract: Angular correlations between unidentified charged trigger particles and various species of charged associated particles (unidentified particles, pions, kaons, protons and antiprotons) are measured by the ALICE detector in p-Pb collisions at a nucleon-nucleon centre-of-mass energy of 5.02 TeV in the transverse-momentum range 0.3 < p(T) < 4 GeV/c. The correlations expressed as associated yield per trigger particle are obtained in the pseudorapidity range vertical bar n(lab)vertical bar < 0.8. Fourier coefficients are extracted from the long-range correlations projected onto the azimuthal angle difference and studied as a function of p(T) and in intervals of event multiplicity. In high-multiplicity events, the second-order coefficient for protons, 4, is observed to be smaller than that for pions, v(2)(pi), up to about p(T) = 2 GeV/c. To reduce correlations due to jets, the per-trigger yield measured in low-multiplicity events is subtracted from that in high-multiplicity events. A two-ridge structure is obtained for all particle species. The Fourier decomposition of this structure shows that the second-order coefficients for pions and kaons are similar. The v(2)(p) is found to be smaller at low P-T and larger at higher p(T) than v(2)(pi), with a crossing occurring at about 2 GeV/c. This is qualitatively similar to the elliptic-flow pattern observed in heavy-ion collisions. A mass ordering effect at low transverse momenta is consistent with expectations from hydrodynamic model calculations assuming a collectively expanding system. (C) 2013 CERN. Published by Elsevier B.V. All rights reserved.
271 citations
Authors
Showing all 50632 results
Name | H-index | Papers | Citations |
---|---|---|---|
Younan Xia | 216 | 943 | 175757 |
Peer Bork | 206 | 697 | 245427 |
Ralph Weissleder | 184 | 1160 | 142508 |
Hyun-Chul Kim | 176 | 4076 | 183227 |
Gregory Y.H. Lip | 169 | 3159 | 171742 |
Yongsun Kim | 156 | 2588 | 145619 |
Jongmin Lee | 150 | 2257 | 134772 |
James M. Tiedje | 150 | 688 | 102287 |
Guanrong Chen | 141 | 1652 | 92218 |
Kazunori Kataoka | 138 | 908 | 70412 |
Herbert Y. Meltzer | 137 | 1148 | 81371 |
Peter M. Rothwell | 134 | 779 | 67382 |
Tae Jeong Kim | 132 | 1420 | 93959 |
Shih-Chang Lee | 128 | 787 | 61350 |
Ming-Hsuan Yang | 127 | 635 | 75091 |